Multimodal pain management after total joint arthroplasty.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 21655901.
- Also identified by DOI 10.2106/JBJS.J.01095.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Adequate postoperative pain control in patients who have undergone total joint arthroplasty allows faster rehabilitation and reduces the rate of postoperative complications. Multimodal pain management involves the introduction of adjunctive pain control methods in an attempt to control pain with less reliance on opioids and fewer side effects. Current research suggests that traditional nonsteroidal anti-inflammatory drugs (NSAIDs) and the associated cyclooxygenase type-2 (COX-2) inhibitors improve pain control in most cases. Nearly all multimodal pain management modalities have a safe side-effect profile when they are added to existing methods. The exception is the administration of DepoDur (extended-release epidural morphine) to elderly or respiratory-compromised patients because of a potential for hypoxia and cardiopulmonary events.
Medical subject headings
- Analgesia
- Anti-Inflammatory Agents, Non-Steroidal
- Arthroplasty, Replacement
- Cyclooxygenase 2 Inhibitors